Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Rises By 85.5%

SeaStar Medical Holding Corporation (NASDAQ:ICU) saw a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 286,335 shares, a growth of 85.5% from the January 29th total of 154,400 shares. Approximately 7.6% of the company’s shares are sold short. Based on an average daily trading volume, of 108,978 shares, the short-interest ratio is currently 2.6 days. Based on an average daily trading volume, of 108,978 shares, the short-interest ratio is currently 2.6 days. Approximately 7.6% of the company’s shares are sold short.

SeaStar Medical Stock Performance

Shares of NASDAQ ICU opened at $2.76 on Monday. SeaStar Medical has a 52-week low of $2.20 and a 52-week high of $25.70. The stock has a market cap of $10.46 million, a P/E ratio of -0.17 and a beta of -1.04. The firm has a 50 day moving average price of $2.46 and a 200 day moving average price of $4.83.

Analyst Ratings Changes

A number of analysts recently commented on ICU shares. Wall Street Zen upgraded SeaStar Medical to a “hold” rating in a research report on Saturday, January 10th. Weiss Ratings restated a “sell (e+)” rating on shares of SeaStar Medical in a report on Thursday, January 22nd. Finally, Maxim Group set a $6.00 target price on shares of SeaStar Medical in a report on Thursday, February 12th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has an average rating of “Sell” and an average target price of $6.00.

Institutional Trading of SeaStar Medical

Several hedge funds have recently added to or reduced their stakes in ICU. XTX Topco Ltd lifted its holdings in SeaStar Medical by 395.4% during the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after acquiring an additional 48,674 shares in the last quarter. Trinity Financial Advisors LLC raised its position in shares of SeaStar Medical by 233.3% during the third quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock worth $28,000 after purchasing an additional 35,000 shares during the period. Millennium Management LLC bought a new position in shares of SeaStar Medical during the 3rd quarter valued at about $102,000. Finally, Jane Street Group LLC bought a new position in shares of SeaStar Medical during the 4th quarter valued at about $30,000. Institutional investors and hedge funds own 1.69% of the company’s stock.

SeaStar Medical Company Profile

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.